P glycoprotein and the mechanism of multidrug resistance

Novartis Foundation Symposium

Volumn 243, Issue , 2002, Pages 54-68

  Váradi, András ^a   Szakács, Gergely ^b   Bakos, Éva ^a   Sarkadi, Balázs ^b  

^a INSTITUTE OF ENZYMOLOGY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARCHAEAL PROTEIN; BACTERIAL PROTEIN; GLYCOPROTEIN P;

ACTIVE TRANSPORT; BINDING SITE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; DIMERIZATION; DRUG ANTAGONISM; HUMAN; HYDROLYSIS; HYDROPHOBICITY; METABOLISM; MULTIDRUG RESISTANCE; PHYSIOLOGY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION;

ADENOSINE TRIPHOSPHATE; ARCHAEAL PROTEINS; BACTERIAL PROTEINS; BINDING SITES; BIOLOGICAL TRANSPORT, ACTIVE; CATALYSIS; DIMERIZATION; DRUG RESISTANCE, MULTIPLE; HUMANS; HYDROLYSIS; HYDROPHOBICITY; MODELS, MOLECULAR; P-GLYCOPROTEIN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036361915     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (44)

1. Ambudkar SV, Lelong IH, Zhang J, Cardarelli CO, Gottesman MM, Pastan I 1992 Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. Proc Natl Acad Sci USA 89:8472-8476
2. Armstrong S, Tabemero L, Zhang H, Hermodsen M, Stauffacher C 1998 Powering the ABC transporters: the 2.5A of the ABC domain of RbsA. Pediatr Pulmonol 17:91-93
3. Azzaria M, Schurr E, Gros P 1989 Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance. Mol Cell Biol 9:5289-5297
4. Bakos É, Klein I, Welker E et al 1997 Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region. Biochem J 323: 777-783
5. Chen CJ, Chin JE, Ueda K et al 1986 Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47:381-389
6. Cordon-Cardo C, O'Brien JP, Casals D et al 1989 Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 86:695-698
7. Cornwell MM, Tsuruo T, Gottesman MM, Pastan I 1987 ATP-binding properties of P glycoprotein from multidrug-resistant KB cells. FASEB J 1:51-54
8. Diederichs K, Diez J, Greller G et al 2000 Crystal structure of MalK, the ATPase subunit of the trehalose/maltose ABC transporter of the archaeon Thermococcus litoralis. EMBO J 19: 5951-5961
9. Gros P, Croop J, Housman D 1986 Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 47:371-380
10. Hopfner KP, Karcher A, Shin DS et al 2000 Structural biology of the Rad50 ATPase. ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily. Cell 101:789-800
11. Hrycyna CA, Ramachandra M, Ambudkar SV et al 1998a Mechanism of action of human P-glycoprotein ATPase activity: photochemical cleavage during a catalytic transition state using othovanadate reveals cross-talk between the two ATP sites. J Biol Chem 273: 16631-16634
12. Hrycyna CA, Airan LE, Germann UA, Ambudkar SV, Pastan I, Gottesman MM 1998b Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport. Biochemistry 37:13660-13673
13. Hung LW, Wang IX, Nikaido K, Liu PQ, Ames GF, Kim SH 1998 Crystal structure of the ATP-binding subunit of an ABC transporter. Nature 396:703-707
14. Jones PM, George AM 1999 Subunit interactions in ABC transporters: towards a functional architecture. FEMS Microbiol Lett 179:187-202
15. Klein I, Sarkadi B, Váradi A 1999 An inventory of the human ABC proteins. Biochim Biophys Acta 1461:237-262
16. Krupka RM 1999 Uncoupled active transport mechanisms accounting for low selectivity in multidrug carriers: P-glycoprotein and SMR antiporters. J Membr Biol 127:129-143
17. Loo TW, Clarke DM 1999 The transmembrane domains of the human multidrug resistance P-glycoprotein are sufficient to mediate drug binding and trafficking to the cell surface. J Biol Chem 274:24759-24765
18. Müller M, Bakos É, Welker E et al 1996 Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein. J Biol Chem 271:1877-1883
19. Qu Q, Sharom SJ 2001 FRET Analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated. Biochemistry 40:1413-1422
20. Rao VV, Dahlheimer JL, Bardgett ME et al 1999 Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci USA 96:3900-3905
21. Rosenberg MF, Callaghan R, Ford RC, Higgins CF 1997 Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J Biol Chem 272:10685-10694
22. Sankaran B, Bhagat S, Senior AE 1997a Inhibition of P-glycoprotein ATPase activity by procedures involving trapping of nucleotide in catalytic sites. Arch Biochem Biophys 341:160-169
23. Sankaran B, Bhagat S, Senior AE 1997b Inhibition of P-glycoprotein ATPase activity by beryllium fluoride. Biochemistry 36:6847-6853
24. Sarkadi B, Price EM, Boucher RC, Germann UA, Scarborough GA 1992 Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem 267:4854-4858
25. Sauna ZE, Ambudkar SV 2000 Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. Proc Natl Acad Sci USA 97:2515-2520
26. Schinkel AH, Smit JJ, van Tellingen O et al 1994 Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491-502
27. Schinkel AH, Mayer U, Wagenaar E et al 1997 Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 94:4028-4033
28. Senior AE, Al-Shawi MK, Urbatsch IL 1995 The catalytic cycle of P-glycoprotein. FEBS Lett 377:285-289
29. Senior AE, Gadsby DC 1997 ATP hydrolysis cycles and mechanism in P-glycoprotein and CFTR. Semin Cancer Biol 8:143-150
30. Sharma S, Rose DR 1995 Cloning, overexpression, purification, and characterization of the carboxyl-terminal nucleotide binding domain of P-glycoprotein. J Biol Chem 270:14085-14093
31. Shepard RL, Winter MA, Hsaio SC, Pearce HL, Beck WT, Dantzig AH 1998 Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein. Biochem Pharmacol 56:719-727
32. Szabó K, Welker E, Bakos É et al 1998 Drug-stimulated nucleotide trapping in the human multidrug transporter MDR1: cooperation of the nucleotide binding domains. J Biol Chem 273:10132-10138
33. Szakács G, Özvegy CS, Bakos É, Sarkadi B, Váradi A 2000 Transition-state formation in ATPase-negative mutants of human MDR1 protein. Biochem Biophys Res Commun 276:1314-1319
34. Szakács G, Özvegy CS, Bakos É, Sarkadi B, Váradi A 2001 Role of the conserved Gly residue in the ABC-signature motif of human MDR1 in the drug-induced allosteric control of ATPase activity. Biochem J 356:71-75
35. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC 1987 Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735-7738
36. Urbatsch IL, Gimi K, Wilke-Mounts S, Senior AE 2000a Conserved Walker A Ser residues in the catalytic sites of P-glycoprotein are critical for catalysis and involved primarily at the transition state step. J Biol Chem 275:25031-25038
37. Urbatsch IL, Gimi K, Wilke-Mounts S, Senior AE 2000b Investigation of the role of glutamine-471 and glutamine-1114 in the two catalytic sites of P-glycoprotein. Biochemistry 39:11921-11927
38. Urbatsch IL, Beaudet L, Carrier I, Gros P 1998 Mutations in either nucleotide-binding site of P-glycoprotein (mdr3) prevent vanadate trapping of nucleotide at both sites. Biochemistry 37:4592-4602
39. Urbatsch IL, Sankaran B, Weber J, Senior AE 1995a P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site. J Biol Chem 270:19383-19390
40. Urbatsch IL, Sankaran B, Bhagat S, Senior AE 1995b Both P-glycoprotein nucleotide-binding sites are catalytically active. J Biol Chem 270:26956-26961
41. van Helvoort A, Smith AJ, Sprong H et al 1996 MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87:507-517
42. Walker JE, Saraste M, Runswick MJ, Gay NJ 1982 Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myoisn, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J 1:945-951
43. Wang C, Castro FA, Wilkes DM, Altenberg G A 1999 Expression and purification of the first nucleotide-binding domain and linker region of human multidrug resistance gene product: comparison of fusions to gluthation S-transferase, thioredoxin and maltose-binding protein. Biochem J 338:77-81
44. Zheleznova EE, Markham PN, Neyfakh AA, Brennan RG 1999 Structural basis of multidrug recognition by BmrR, a transcription activator of a multidrug transporter. Cell 96:353-336